Is ACADIA Pharmaceuticals Inc. (ACAD) halal to invest in?

As of يونيو 2026, based on AAOIFI Shariah screening standards, ACADIA Pharmaceuticals Inc. (ACAD) is currently rated as "Not Halal" with a compliance grade of F (Non-Compliant). The screening examines business activities (qualitative) and three financial ratios: debt-to-market-cap (1.4%), interest-bearing deposits to market cap (26.2%), and prohibited income (13.0%). Thresholds are 30%, 30%, and 5% respectively. Screen ACAD and 10,000+ stocks free at HalalScreener.app.

What is ACADIA Pharmaceuticals Inc.'s Shariah compliance score?

ACADIA Pharmaceuticals Inc.'s (ACAD) compliance score is being calculated. Check HalalScreener.app for the latest AAOIFI screening results.

Does ACADIA Pharmaceuticals Inc. pass AAOIFI screening?

ACADIA Pharmaceuticals Inc. (ACAD) does not pass AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (ACAD: 1.4%), (3) interest-bearing deposits below 30% (ACAD: 26.2%), and (4) prohibited income below 5% (ACAD: 13.0%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for ACADIA Pharmaceuticals Inc. stock?

ACADIA Pharmaceuticals Inc. (ACAD) has a non-permissible income ratio of 12.98%. Muslim investors should purify this percentage of any dividends received and capital gains realized from ACAD shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen ACADIA Pharmaceuticals Inc. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for ACADIA Pharmaceuticals Inc. (ACAD) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about ACAD's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

Is ACADIA Pharmaceuticals Inc. (ACAD) halal? Not Halal. Based on AAOIFI screening, ACADIA Pharmaceuticals Inc. passes the business activity screen but fails financial ratio screens with a compliance score of 0/100 (Grade: F).

ACAD: Is ACADIA Pharmaceuticals Inc. Halal?

Not Halal

ACADIA Pharmaceuticals Inc.

NASDAQHealthcareUS

$20.89

-2.93%

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Sector: Healthcare · Industry: Biotechnology

Shariah Compliance Status

معيار أيوفي 21تحديث ١٠ يونيو ٢٠٢٦

Non-Compliant

Fails Shariah screening

0Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Failed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap1.4% / 30.0%

Compliance History

Not Halalnow
since Jun 2026
Doubtful
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Screened: Jun 10, 2026Fiscal: Q1 2026Source: FMP

Financial Overview

Market Cap

3.6B

Price

$20.89

Sector

Healthcare

Industry

Biotechnology

Halal Alternatives in Healthcare

This stock is not Shariah-compliant. Here are halal alternatives from the same sector, ranked by compliance score:

0001.KLA+

Supercomnet Technologies Bhd

$0.50

-0.03%

0002.KLA+

Kotra Industries Bhd

$3.76

+0.00%

0075.KLA+

LYC Healthcare Bhd

$0.01

+0.00%

0101.KLA+

TMC Life Sciences Bhd

$0.44

-0.01%

0155.KLA+

Malaysian Genomics Resource Centre Bhd

$0.28

+0.02%

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track ACAD and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

الأسئلة الشائعة

هل ACADIA Pharmaceuticals Inc. (ACAD) حلال للاستثمار؟

ACADIA Pharmaceuticals Inc. (ACAD) is rated Not Halal under AAOIFI Standard 21 screening. It fails either the business activity screen (primary involvement in prohibited sectors such as conventional banking, alcohol, or gambling) or one of the quantitative financial ratio thresholds. Muslim investors should avoid or exit this position.

لماذا حصل ACADIA Pharmaceuticals Inc. على تقييم توافق F؟

ACADIA Pharmaceuticals Inc. (ACAD) received a grade of F (Non-Compliant) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 1.4% (limit 30%); interest-bearing deposits of 26.2% (limit 30%); prohibited income of 12.98% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

ما الذي قد يغير حكم ACADIA Pharmaceuticals Inc. الشرعي؟

ACADIA Pharmaceuticals Inc.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

كم مرة يُعاد فحص ACADIA Pharmaceuticals Inc. للتوافق الشرعي؟

ACADIA Pharmaceuticals Inc. (ACAD) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 10, 2026.

مفحوص وفق معيار أيوفي رقم 21 · لأغراض إعلامية فقط. استشر مستشاراً مالياً إسلامياً مؤهلاً قبل الاستثمار.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.